Literature DB >> 23462301

Human brucellosis in the People's Republic of China during 2005-2010.

Zhijun Zhong1, Shuang Yu, Xichun Wang, Shicun Dong, Jie Xu, Yufei Wang, Zeliang Chen, Zhihua Ren, Guangneng Peng.   

Abstract

Brucellosis is a worldwide re-emerging zoonotic disease. It remains a serious public health problem in many developing countries including China. This review summarizes the epidemiological characteristics, morbidity, and endemic distributions of human brucellosis in the People's Republic of China for the period 2005-2010. From 2005 to 2010, the incidence of human brucellosis rose substantially in China, especially in the provinces of Inner Mongolia, Shanxi3, Heilongjiang, Hebei, Jilin, and Shanxi1. Meanwhile human brucellosis increased gradually in some southern provinces, such as Henan, Guangdong, and Fujian. Due to the rapid expansion of human brucellosis in China, surveillance and prevention of this disease has been greatly challenged.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23462301     DOI: 10.1016/j.ijid.2012.12.030

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  35 in total

1.  Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.

Authors:  Edurne Imbuluzqueta; Carlos Gamazo; Hugo Lana; Miguel Ángel Campanero; David Salas; Ana Gloria Gil; Elisa Elizondo; Nora Ventosa; Jaume Veciana; María J Blanco-Prieto
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

2.  A case report of endocarditis and spondylitis caused by Brucella melitensis biovar 3.

Authors:  Huan Zhang; Songsong Xie; Yueli Wang; Xiaoli Zhao; Jihai Yi; Zhen Wang; Qi Liu; Xiaoyu Deng; Bingjie Li; Buyun Cui; Yuanzhi Wang; Chuangfu Chen
Journal:  BMC Infect Dis       Date:  2021-05-20       Impact factor: 3.090

3.  Value of magnetic resonance imaging in brucellar spondylodiscitis.

Authors:  Xiaohui Yang; Qin Zhang; Xinghua Guo
Journal:  Radiol Med       Date:  2014-05-27       Impact factor: 3.469

4.  Diagnosis and management of spinal tuberculosis combined with brucellosis: A case report and literature review.

Authors:  Dexin Zou; Junlin Zhou; Xiaobing Jiang
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

5.  Participatory and Transdisciplinary Studies of Brucella Infection in Humans and Animals in Yunnan Province, China-Lessons Learned.

Authors:  Wengui Li; Xiangdong Yang; Johanna F Lindahl; Guorong Yang; Jeffrey Gilbert; Fred Unger
Journal:  Trop Med Infect Dis       Date:  2021-07-15

6.  Human brucellosis occurrences in inner mongolia, China: a spatio-temporal distribution and ecological niche modeling approach.

Authors:  Peng Jia; Andrew Joyner
Journal:  BMC Infect Dis       Date:  2015-02-03       Impact factor: 3.090

7.  Cultural drivers and health-seeking behaviours that impact on the transmission of pig-associated zoonoses in Lao People's Democratic Republic.

Authors:  Stephanie Burniston; Anna L Okello; Boualam Khamlome; Phouth Inthavong; Jeffrey Gilbert; Stuart D Blacksell; John Allen; Susan C Welburn
Journal:  Infect Dis Poverty       Date:  2015-03-02       Impact factor: 4.520

8.  Spatial analysis on human brucellosis incidence in mainland China: 2004-2010.

Authors:  Junhui Zhang; Fei Yin; Tao Zhang; Chao Yang; Xingyu Zhang; Zijian Feng; Xiaosong Li
Journal:  BMJ Open       Date:  2014-04-08       Impact factor: 2.692

9.  Septic arthritis caused by Brucella melitensis in urban Shenzhen, China: a case report.

Authors:  Tak Man Wong; Nan Lou; Wentao Jin; Felix Leung; Michael To; Frankie Leung
Journal:  J Med Case Rep       Date:  2014-11-14

10.  First Case of Human Brucellosis Caused by Brucella melitensis in Korea.

Authors:  Hyeong Nyeon Kim; Mina Hur; Hee Won Moon; Hee Sook Shim; Hanah Kim; Misuk Ji; Yeo Min Yun; Sung Yong Kim; Jihye Um; Yeong Seon Lee; Seon Do Hwang
Journal:  Ann Lab Med       Date:  2016-07       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.